Anthera Pharmaceuticals

Anthera Pharmaceuticals

Biotechnology, Industrial BLVD Ste B, Hayward, , 94545, California, 25801, United States, 11-50 Employees

anthera.com

  • LinkedIn

phone no Phone Number: +15*********

Who is ANTHERA PHARMACEUTICALS

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical ne...

Read More

map
  • 25801 Industrial BLVD Ste B, Hayward, California, 94545, United States Headquarters: 25801 Industrial BLVD Ste B, Hayward, California, 94545, United States
  • 2004 Date Founded: 2004
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ANTHERA PHARMACEUTICALS

Anthera Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Anthera Pharmaceuticals

Answer: Anthera Pharmaceuticals's headquarters are located at Industrial BLVD Ste B, Hayward, , 94545, California, 25801, United States

Answer: Anthera Pharmaceuticals's phone number is +15*********

Answer: Anthera Pharmaceuticals's official website is https://anthera.com

Answer: Anthera Pharmaceuticals's revenue is $25 Million to $50 Million

Answer: Anthera Pharmaceuticals's SIC: 2834

Answer: Anthera Pharmaceuticals's NAICS: 325412

Answer: Anthera Pharmaceuticals has 11-50 employees

Answer: Anthera Pharmaceuticals is in Biotechnology

Answer: Anthera Pharmaceuticals contact info: Phone number: +15********* Website: https://anthera.com

Answer: Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. Anthera has two product candidates, Sollpura, in Phase 3 development for Exocrine Pancreatic Insufficiency due to Cystic Fibrosis and blisibimod, in Phase 2 development for IgA nephropathy. NASDAQ: ANTH

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access